New medication approved by FDA for OFF symptoms Posted on May 22, 2020 by Phil Franchina Kynmobi Sunovion Pharmaceuticals announced that the Food and Drug Administration (FDA) approved Kynmobi® (apomorphine hydrochloride), a new sublingual medication for fast relief of OFF symptoms of Parkinson’s disease (PD). Apomorphine […] Read More
New drug approved for OFF episodes Posted on April 27, 2020 by Phil Franchina Today, Neurocrine Biosciences announced that the Food and Drug Administration (FDA) approved ONGENTYS ® (opicapone), a new medication for treatment of Parkinson’s disease (PD). Opicapone is a catechol-O-methyltransferase (COMT) inhibitor […] Read More
CORONAVIRUS DISEASE 2019 AND THE PD COMMUNITY Posted on March 20, 2020May 27, 2020 by Phil Franchina APDA COVID-19 INFORMATION & RESOURCES: The American Parkinson Disease Association (APDA) is closely monitoring the Coronavirus Disease 2019 (also known as COVID-19) situation. We are eager to resume in-person events, […] Read More
The 26th Annual Parkinson’s Unity Walk Posted on January 13, 2020January 13, 2020 by Phil Franchina The American Parkinson Disease Association (APDA) is a proud partner of the 26th Annual Parkinson’s Unity Walk taking place on Saturday, April 25, 2020 in Central Park, New York City. 100% […] Read More
The FDA approves F-Dopa PET imaging to aid in early diagnosis of Parkinson’s disease Posted on January 8, 2020January 8, 2020 by Dr. Rebecca Gilbert The FDA approves F-Dopa PET imaging to aid in early diagnosis of Parkinson’s disease The FDA recently approved Flourodopa F18 (F-Dopa), a radioactive tracer for positron emission tomography (PET) that […] Read More
Deep brain stimulation and swimming Posted on December 4, 2019December 4, 2019 by Phil Franchina Deep brain stimulation and swimming Deep brain stimulation (DBS) is a surgical treatment for Parkinson’s disease (PD) symptoms in which small wires are inserted deep into the brain to deliver […] Read More
Promising results from the University of Pittsburgh APDA Center for Advanced Research Posted on October 24, 2019December 12, 2019 by Phil Franchina Promising results from the University of Pittsburgh APDA Center for Advanced Research Building off of pivotal APDA-funded work highlighted here, Dr. J. Timothy Greenamyre and his team, published a new […] Read More
Taking Parkinson’s education to the farmers market: educating under-served communities Posted on September 16, 2019September 16, 2019 by Phil Franchina Taking Parkinson’s education to the farmers market: educating under-served communities Dr. Lynda Nwabuobi, Movement Disorder Fellow at Columbia Presbyterian Medical Center in New York City, attended APDA’s Diversity in Parkinson’s […] Read More
New medication, Istradefylline, gets approved for Parkinson’s disease Posted on September 4, 2019 by Phil Franchina New medication, Istradefylline, gets approved for Parkinson’s disease On August 27, 2019, pharmaceutical company Kyowa Kirin received FDA approval for Istradefylline, a new medication for Parkinson’s disease (PD) to be […] Read More
APDA Seed Funding Leads to Prestigious NIH Research Grant Posted on August 16, 2019August 16, 2019 by Phil Franchina APDA Seed Funding Leads to Prestigious NIH Research Grant APDA is exceptionally proud to congratulate Dr. Beom-Chan Lee, APDA Research Grant awardee on receiving a recently-awarded National Institutes of Health (NIH) R21 grant. Read More
